Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Nootropic α7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators
- Herman J Ng, E. R. Whittemore, K. Gee
- Biology, PsychologyProceedings of the National Academy of Sciences
- 8 May 2007
A selective α7 nAChR-positive allosteric modulator (PAM) from a library of GABAA receptor PAMs is generated, which corrects sensory-gating deficits and improves working memory, effects consistent with cognitive enhancement in rodent models.
Negative Allosteric Modulation of Nicotinic Acetylcholine Receptors Blocks Nicotine Self-Administration in Rats
- R. Yoshimura, D. Hogenkamp, K. Gee
- Biology, ChemistryJournal of Pharmacology and Experimental…
- 1 December 2007
UCI-30002 represents validation of the concept that negative allosteric modulators may have significant benefits as a strategy for treating nicotine addiction and encourages the development of subtype-selective modulators.
Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: a novel systemically active ionotropic glutamate receptor antagonist.
- R. Woodward, J. E. Huettner, M. Tran, J. Guastella, J. Keana, E. Weber
- Biology, ChemistryThe Journal of pharmacology and experimental…
- 1 December 1995
The results indicate that ACEA-1011 is a systemically active broad selectivity ionotropic glutamate receptor antagonist.
MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity
It is concluded that MX1013, a dipeptide pan‐caspase inhibitor, has a good combination of in vitro and in vivo properties and has the ability to protect cells from a variety of apoptotic insults.
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
The trial demonstrates that a type I PAM can be safely administered to humans and that it has potential positive neurocognitive effects in central nervous system (CNS) disorders.
Allosteric Modulation of Related Ligand-Gated Ion Channels Synergistically Induces Long-Term Potentiation in the Hippocampus and Enhances Cognition
Combined transient application of two allosteric modulators that individually inhibit α5 GABAARs and enhance α7 nAChRs causes long-term potentiation of mossy fiber stimulation-induced excitatory postsynaptic currents (EPSC) from CA1 pyramidal neurons of rat hippocampal slices.
Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism-like behaviors in the BTBR mouse model
4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist.
10e (4-hydroxy-N-[2-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperid ine, Co 101244/PD 174494) had the optimum pharmacological profile and was selected for further biological evaluation.
Pharmacological profile of a 17β-heteroaryl-substituted neuroactive steroid
- D. Hogenkamp, M. Tran, R. Yoshimura, Timothy B C Johnstone, R. Kanner, K. Gee
- Biology, ChemistryPsychopharmacology
- 28 February 2014
UCI-50027 is an orally active neuroactive steroid with pharmacological activity consistent with a gamma-aminobutyric acid(A) receptor PAM that has an improved separation between anticonvulsant/anxiolytic and rotarod effects, potent activity as an anticonVulsant and anxIOlytic when compared to ganaxolone.